Skip to main content
. 2023 Jun 1;133(11):e170236. doi: 10.1172/JCI170236

Figure 2. Approved and experimental direct-acting compounds with broad-spectrum antiviral activity.

Figure 2

Depicted here is a generic viral life cycle. Examples of classes of inhibitors with broad-spectrum antiviral activity are connected to the specific stages of the viral life cycle or cellular process they target.